Search Results
Results found for "Shane Wright"
- How Schild Analysis Protects Your Conclusions in GPCR Research
Why this matters Receptor distribution shapes incretin hormone drug effects across islets and neural Acting on the right signals today shapes tomorrow’s breakthroughs — and prevents delays others won’t
- How Collaboration Drives GPCR Discoveries
The future of discovery will belong to scientists who know how to build the right partnerships and stay That mindset shaped his partnership with JB, the chemist who would eventually help his lab visualize This is where GPCR science is heading: toward deeper integration, shared tools, and partnerships that
- Better GPCR Drug Discovery Decisions Start With Structured Learning
The ability to access the right framework, detect risk early, and act on emerging signals determines initiative brings together field experts to advance collective understanding of how GPCR-mediated signaling shapes Contribute to shaping scientific direction in cellular biochemistry.
- Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for ...
and, in this review, we have compared expression of GPCR mRNAs in human islets obtained from normal weight range donors, and those with a weight range classified as obese.
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
We are bursting with pride in sharing it with you, and we sincerely want to thank you for your support That's right, all the tidbits below will be for Premium Members ' eyes only. Septerna Touches New High, To Report SEP-786 Data In Mid-2025 How GPCR agonists, including antibodies, are shaping
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
because the target is wrong—but because the chemical matter interacting with that target lacks the right In this lesson, you’ll gain: A strategic view of how chemical scaffolds shape pharmacologic outcomes Those who learn now will shape the drugs others spend the next decade trying to understand. 40 years
- Asking Better Questions in Science: A Practical Guide for Emerging Researchers
The expert they admire is right there, but the fear of sounding unprepared wins. This mindset shapes careers far more than publications alone.
- Inverse Agonists, Lymphatic Fixes & β-arrestin Tricks
GPCR Updates We want your feedback - Help shape the future of Dr. GPCR. Your voice matters. Every insight you share helps us build a smarter, more supportive GPCR community—together. GPCR Ambassador - Share & refer with Dr. GPCR. Help grow the GPCR community by joining the Dr. It’s a simple way to share valuable resources and support the field—one connection at a time.
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
Overcoming them requires careful assay design and strategic use of the right fluorescent probes. Source: Way GP, Sailem H, Shave S, Kasprowicz R, Carragher NO. CB 2 -expressing HEK cell lines are labeled with CELT-331 at 80 nM (right), while competition with the
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Advantages of Fluorescent Ligands in GPCR Drug Screening for CNS Choosing the right tools is important for the success of drug discovery, just as much as choosing the right targets.
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
Shape the next generation of cellular biochemistry research. scientists and translational teams, Premium keeps you informed on the science, careers, and business moves shaping Those who act on the right signals today will lead tomorrow’s breakthroughs—and avoid delays others won
- The Quiet Power of RGS Proteins: Rethinking Pain Pathways through GPCR Biology
... and honestly, like with the trials, they were not really that sufficiently better than opioids, right
- Identification of hub genes in the subacute spinal cord injury in rats
The differentially expressed genes (DEGs) and weighted correlation network analysis (WGCNA) were performed
- The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway
Or the right things are moving in the wrong order. 👉 That’s how biotech teams burn through capital without Real biotech traction starts when decisions are driven by shared strategy, not disconnected deliverables these lines blur, so do accountability and execution. 3️⃣ The third and hardest shift is restoring shared But the moment they shift from disconnected workstreams to a shared, milestone-driven roadmap tied to
- The Hidden Cost of Ambition in Biotech Leadership
these signals the same underlying problem: 👉 The company has not explicitly chosen what matters most right Not every opportunity strengthens the company right now.
- Inside Out: Mapping GPCRs from Membrane Codes to Market Moves
Additionally, new studies reveal how phosphorylation barcodes shape arrestin engagement, a biased NTSR1 Ilana Kotliar share how three decades of curiosity evolved into a tech-powered platform for mapping GPCR-RAMP GPCR Publication Highlights GRK-Specific Phosphorylation Barcodes Shape Arrestin Engagement with
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
4️⃣ Comparative value: Have you positioned your therapeutic against the right standard or competitor, 5️⃣ Patient targeting rationale: Are you selecting the right patient subgroup with a clear justification
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
latest episodes → Read our podcast highlights Inside Revvity’s GPCR Journey: How Decades of Discovery Shaped Acting on the right signals today prevents tomorrow’s delays—and puts you ahead when budgets and timelines
- Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota..
Moreover, independent of glucose control or weight loss, the anti-inflammatory actions of GLP-1RAs require
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...
strategy is the so-called metabolic surgery whose beneficial effects are beyond dietary restrictions and weight
- 📰 GPCR Weekly News, June 19 to 25, 2023
As we approach the event, we have some news to share: We’ve decided to make this event a trainee day Industry News Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim
- Understanding the Journey: Catherine Demery's Path to Addiction Science
Watch Episode 172 What happens when the career you planned no longer feels right? And so, that certainly shaped my interests and passions as a scientist."
- Why Biotech Fundraising Fails Due to Intellectual Property Gaps
Slides list filings and dates, but do not explain how those rights support the fundraising narrative Typical problem areas include: 👉 University licenses with complex or restrictive terms 👉 Unclear rights
- The One Reason Why Biotech Startups Fail More Often Than They Should
Not because the science stops working, but because the organization stops knowing what matters most right Teams execute tasks without a shared understanding of which decisions those tasks are meant to inform Strategy creates a shared filter that connects science execution and business reality. ✅ At its core,
- From Failed Experiments to Predictive GPCR Models
At one point, he even questioned whether research was the right career for him. with chemists, biologists, and pharmacologists not only made his predictions more useful, but also shaped Good mentors help shape thinking without prescribing decisions.
- From Lab Bench to Boardroom: The Unexpected Path of a Medicinal Chemist
GPCR Podcast, she shares how her background in medicinal chemistry paved the way to co-founding Celtarys , a company now shaping the future of GPCR assay tools.
- 📰 GPCR Weekly News, February 19 to 25, 2024
If you want to share your work with our community, please don’t hesitate to fill out this form. You'll share your contributor articles with the community, stay updated with GPCR literature, join a Fragment-Based Design, Synthesis, and Characterization of Aminoisoindole-Derived Furin Inhibitors A Bright
- Why Fundraising Mistakes Kill Strong Biotech Startups
or reflecting on a recent round, this is an opportunity to recognize where pressure may already be shaping logic quietly replaces deliberate strategy. 👉 This is why strong biotech startups often appear busiest right In reality, the most damaging mistakes rarely appear at the surface. 👉 They take shape much earlier, Strategy continues to shape decisions even when external pressure rises. ✅ This is the point where biotech
- How to Avoid the Most Common Gaps in Your Biotech Pitch
A clear, strategic pitch doesn’t just share information. It communicates that you know who you’re building for, why now is the right time, and how your solution
- Regulation of rod photoreceptor function by farnesylated G-protein γ-subunits
Bright illumination triggered Gαt1 translocation from the rod outer to inner segments in all three transgenic























